APA (7th ed.) Citation

F, B., S, V., E, D., C, A., I, G., M, P., . . . C, J. (2026). Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial. American journal of hematology, 101(8), 1799. https://doi.org/10.1002/ajh.70336

Chicago Style (17th ed.) Citation

F, Bernaudin, et al. "Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial." American Journal of Hematology 101, no. 8 (2026): 1799. https://doi.org/10.1002/ajh.70336.

MLA (9th ed.) Citation

F, Bernaudin, et al. "Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial." American Journal of Hematology, vol. 101, no. 8, 2026, p. 1799, https://doi.org/10.1002/ajh.70336.